Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2026-05-07 @ 7:32 PM
Study NCT ID:
NCT03713632
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2018-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
Sponsor:
Organization: